Prognostic factors for survival in extensive‐stage small cell lung cancer: An Italian real‐world retrospective analysis of 244 patients treated over the last decade-Reference-Cited by-同舟云学术

Prognostic factors for survival in extensive‐stage small cell lung cancer: An Italian real‐world retrospective analysis of 244 patients treated over the last decade

Published:2022-11-05 Issue:24 Volume:13 Page:3486-3495
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Longo Vito¹^ORCID,Pizzutilo Pamela¹,Catino Annamaria¹,Montrone Michele¹,Pesola Francesco¹,Marerch Ilaria¹,Galetta Domenico¹

Affiliation:

1. Medical Thoracic Oncology Unit IRCCS Istituto Tumori "Giovanni Paolo II" Bari Italy

Funder

AstraZeneca

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14712

Reference26 articles.

1. GLOBOCAN2020.Lung. Available at:https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf

2. Metastatic sites and survival in lung cancer

3. Small-cell lung cancer

4. Small Cell Lung Cancer

5. Advances in Small Cell Lung Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab;Oncology and Therapy;2024-01-27

2. Predictive modeling of high-grade lung neuroendocrine neoplasms Overall survival and Cancer-specific survival based on a machine learning approach;2024-01-24

3. Treatment patterns and clinical outcomes in 157 patients with extensive-stage small cell lung cancer: real-world evidence from a single-center retrospective study;Frontiers in Oncology;2023-12-04

4. The efficacy of adebrelimab compared with durvalumab and atezolizumab in untreated extensive-stage small-cell lung cancer: a survival analysis of reconstructed patient-level data;Frontiers in Immunology;2023-05-05

5. Prolonged Survival in a Patient With Extensive-Stage Small Cell Lung Cancer in Spite of Discontinued Immunotherapy With Atezolizumab;Cureus;2023-04-18